Jessica Serra | IR |
Mark Foley | CEO |
Dustin Sjuts | President |
Toby Schilke | CFO |
Roman Rubio | SVP, Clinical Development |
Ken Cacciatore | Cowen and Company |
David Amsellem | Piper Sandler |
Seamus Fernandez | Guggenheim |
Nick Rubino | Stifel |
Vamil Divan | Mizuho |
Tim Lugo | William Blair |
Welcome to Revance Therapeutics Third Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, 9th of November 2021. I would now like to turn the conference call over to Jessica Serra, Head of Investor Relations and ESG of Revance. Please go ahead.
Thank you, Laurie.